Search results
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Short Interest Update
ETF DAILY NEWS· 4 days agoGlobal X Genomics & Biotechnology ETF (NASDAQ:GNOM – Get Free Report) was the target of a large increase in short interest in the month of April. As of April 30th, there was ...
Humacyte Inc (HUMA) Q1 2024 Earnings: Aligns with Analyst Projections Amid Strategic Advances
GuruFocus.com via Yahoo Finance· 6 days agoThe anticipated PDUFA date set for ...for Humacyte. In conclusion, Humacyte Inc's Q1 2024 performance reflects a strategic alignment of its developmental...
15 Best ARK Stocks To Buy Now
Insider Monkey via Yahoo Finance· 3 days agoIn this article, we will take a look at the 15 best ARK stocks to buy now. To see more such companies, go directly to 5 Best ARK Stocks To Buy Now....
Applied Therapeutics Inc (APLT) Reports Q1 2024 Earnings: A Deep
Guru Focus· 6 days agoOn May 9, 2024, Applied Therapeutics Inc (APLT, Financial) released its 8-K filing, detailing the financial results for the first quarter ended March 31, 2024. The clinical-stage ...
Equities Analysts Set Expectations for Enanta Pharmaceuticals, Inc.’s Q1 2025 Earnings (NASDAQ:ENTA)
ETF DAILY NEWS· 5 days agoEnanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Free Report) – Research analysts at HC Wainwright issued their Q1...report issued to clients and investors on Tuesday, May 7th.
Analysts Set Expectations for CytomX Therapeutics, Inc.’s Q2 2024 Earnings (NASDAQ:CTMX)
ETF DAILY NEWS· 4 days agoCytomX Therapeutics, Inc. (NASDAQ:CTMX – Free Report) – Analysts at Wedbush issued their Q2 2024 earnings per share estimates...Therapeutics in a research note issued on Thursday ...
Medpace Holdings (MEDP) Rose as it Reported Strong Matrices
Insider Monkey via Yahoo Finance· 6 days agoInvestment management company Vulcan Value Partners recently released its first quarter 2024...
ALX Oncology Holdings Inc (ALXO) Q1 2024 Earnings Analysis: A De
Guru Focus· 6 days agoReported Revenue: $0.00 million, meeting the estimated revenue of $0.00 million for Q1 2024.Net Loss: Reported a GAAP net loss of $35.6 million, surpassing the
Natixis Advisors L.P. Sells 248 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
ETF DAILY NEWS· 5 days agoNatixis Advisors L.P. cut its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 0.4% during the fourth quarter, according to the company in its...the ...
Cassava Sciences posts $25M profit in Q1 amid Alzheimer's trials By Investing.com
Investing.com· 6 days agoCassava Sciences, Inc. (NASDAQ:SAVA), a clinical-stage biotechnology company, announced a profitable...